Stem cell treatment trial for nerve injury
Part of Brain & nervous system, Eyes & vision, Genetic & congenital, Heart & circulation, Hormones & metabolism, Immune system & allergy, Injuries & trauma, Mental health clinical trials.
This study tests whether bone-marrow stem cells can improve nerve function in people with nerve damage that usually doesn’t recover with current care. It also checks whether the treatment is safe and whether people can be followed over time with repeated nerve exams.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have documented nerve damage in the brain/spinal cord or nerves outside the brain that usually won’t improve with standard care
- Your symptoms started at least 6 months ago
- Your current medicines or surgeries (if any) are stable and not expected to quickly reverse the nerve damage
- You are at least 18 and can understand the study and provide consent
- You must be healthy enough for the procedure after your usual doctor gives medical clearance
- You must be able and willing to do follow-up visits and repeat nerve exams
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a single infusion of stem cells from donated umbilical cord tissue can help calm inflammation in the brain after severe traumatic brain injury. It is for patients aged 18–50 who need brain pressure monitoring and are not responding to verbal commands 5 days after sedation is stopped.
This trial tests whether stem cells taken from your own fat and given through an IV can help people with long-term brain damage from a head injury. It is for adults who have not gotten better with standard treatments.
This trial tests whether a patient's own stem cells can be safely injected into the brain to help recovery after a stroke. It is for people who had an ischemic stroke 6 months to 5 years ago and still have moderate to severe symptoms.
This study follows people who receive intranasal stem cell or exosome therapy (tiny packages from special cells) for brain or neurological conditions like stroke, brain injury, or cerebral palsy. Researchers track how well the treatment works by measuring inflammation markers in the blood and monitoring clinical improvements over time.
This study tests a new stem cell treatment called NurOwn for people with early ALS (within 2 years of symptoms) who still have good breathing and daily function. The goal is to see if it can slow the disease.
This trial tests whether injecting neural stem cells into the spine can slow down ALS. It is for people with rapidly progressing ALS who have good lung function and a caregiver to help with visits.
Hear when a new Nervous System Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.